nach oben

Erschienen in:

01.03.2008 | Original Article

Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study

verfasst von: Anna Scotto d’Abusco, Alessandro Corsi, Maria Grazia Grillo, Claudia Cicione, Valentina Calamia, Gianluca Panzini, Anna Sansone, Cesare Giordano, Laura Politi, Roberto Scandurra

Erschienen in: Rheumatology International | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of this pilot study was to analyze the effects of glucosamine (GlcN) and its N-acetyl-phenylalanine derivative (NAPA) in Vitamin A model of osteoarthritis (OA) in rabbits. GlcN or NAPA or saline solution was intra-articularly administered in rabbit OA knees. Histological analysis revealed that treatment with GlcN or NAPA was associated with more homogeneous chondrocyte cellularity, absence of fissures and fragmentation and more intense staining of the matrix with Alcian Blue compared to the articular surfaces of the knees treated with saline solution. Comparative in vitro study performed on rabbit primary chondrocytes revealed that GlcN and NAPA were also able to counteract the IL-1β-upregulation of genes coding for metalloproteases and inflammatory cytokines. Our preliminary in vivo and in vitro studies suggest that GlcN and NAPA could play a disease-modifying protective role in OA by an anti-catabolic effect and an anti-inflammatory activity on chondrocytes.

Sandell LJ, Aigner T (2001) Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 3:107–113PubMedCrossRef

Loeser RF (2006) Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 54:1357–1360PubMedCrossRef

Goldring MB (2000) Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2:459–465PubMedCrossRef

Hamburger MI, Lakhanpal S, Mooar PA, Oster D (2003) Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 32:296–309PubMedCrossRef

Lippiello L, Woodward J, Karpman R, Hammad TA (2000) In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop Relat Res 381:229–240PubMedCrossRef

Oegema TR Jr, Deloria LB, Sandy JD, Hart DA (2002) Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits. Arthritis Rheum 46:2495–2503PubMedCrossRef

Shikhman AR, Amiel D, D’Lima D, Hawng S-B, Hu C, Xu A, Hashimoto S, Kobayashi K, Sasho T, Lotz M (2005) Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis. Ann Rheum Dis 64:89–94PubMedCrossRef

Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gosset C (2001) Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357:251–256PubMedCrossRef

Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC (2002) Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162:2113–2123PubMedCrossRef

10.

Bruyere O, Pavelka K, Rovati LC, Deroisy R, Olejarova M, Gatterova J, Giacovelli G, Reginster JY (2004) Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two years studies. Menopause 11:138–143PubMedCrossRef

11.

Grillo MG, Panzini G, Di Virgilio A, Corsi A, Riminucci M, Bianco P, Politi L, Lorenzini RN, Scandurra R (2004) Intra-articular injection of Vitamin A: a rabbit model to study osteoarthrosis. Scand J Lab Anim Sci 31:3–8

12.

Giordano C, Gallina C, Consalvi V, Scandurra R (1991) Synthesis and properties of d-glucosamine N-peptidyl derivatives as substrate analog inhibitors of papain and cathepsin B. Eur J Med Chem 26:753–762CrossRef

13.

Kirschke H, Kembhavi AA, Bohley P, Barrett AJ (1982) Action of rat liver cathepsin L on collagen and other substrates. Biochem J 201:367–372PubMed

14.

Martel-Pelletier J, Cloutier JM, Pelletier JP (1990) Cathepsin B and cysteine protease inhibitors in human osteoarthritis. J Orthop Res 8:336–344PubMedCrossRef

15.

Lapadula G, Nico B, Cantatore FP, La Canna R, Roncali L, Pipitone V (1995) Early ultrastructural changes of articular cartilage and synovial membrane in experimental Vitamin A-induced osteoarthritis. J Rheum 22:1913–1921PubMed

16.

Gehrsitz A, McKenna LA, Soder S, Kirchner T, Aigner T (2001) Isolation of RNA from small human articular cartilage specimens allows quantification of mRNA expression levels in local articular cartilage defects. J Orthop Res 19(3):478–481PubMedCrossRef

17.

Bassleer C, Rovati L, Franchimont P (1998) Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthr Cartil 6:427–434PubMedCrossRef

18.

Dodge GR, Jimenez SA (2003) Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthr Cartil 11:424–432PubMedCrossRef

19.

Mroz PJ, Silbert JE (2004) Use of 3H-glucosamine and 35S-sulfate with cultured human chondrocytes to determine the effect of glucosamine concentration on formation of chondroitin sulfate. Arthritis Rheum 50:3574–3579PubMedCrossRef

20.

Mroz PJ, Silbert JE (2003) Effects of [3H]glucosamine concentration on [3H]chondroitin sulphate formation by cultured chondrocytes. Biochem J 376:511–515PubMedCrossRef

21.

Uitterlinden EJ, Jahr H, Koevoet JLM, Jenniskens YM, Bierma-Zeinstra SMA, DeGroot J, Verhaar JA, Weinans H, van Osch GJ (2006) Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthr Cartil 14:250–257PubMedCrossRef

22.

Qu C-J, Karjalainen HM, Helminen HJ, Lammi MJ (2006) The lack of effect of glucosamine sulphate on aggrecan mRNA expression and (35)S-sulphate incorporation in bovine primary chondrocytes. Biochim Biophys Acta 1762:453–459PubMed

23.

Bluteau G, Conrozier T, Mathieu P, Vignon E, Herbage D, Mallein-Gerin F (2001) Matrix metalloporotease-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526:147–158PubMed

24.

Shlopov BV, Lie W-R, Mainardi CL, Cole AA, Xhubinskaya S, Hasty KA (1997) Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 40:2065–2074PubMedCrossRef

25.

Lotz M (2001) Cytokines in cartilage injury and repair. Clin Orthop Relat Res 391(Suppl):S108–S115PubMedCrossRef

26.

Mohtai M, Gupta MK, Donlon B, Ellison B, Cooke J, Gibbons G, Schurman DJ, Smith RL (1996) Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes in vitro. J Orthop Res 14:67–73PubMedCrossRef

27.

Kammermann JR, Kincaid SA, Rumph PF, Baird DK, Visco DM (1996) Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis, immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthr Cartil 4:23–34PubMedCrossRef

28.

Gouze JN, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J, Fournel-Gigleux S, Ouzzine M (2001) Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum 44:351–360PubMedCrossRef

29.

Shikhman AR, Kuhn K, Alaaeddine N, Lotz M (2001) N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J Immunol 166:5155–5160PubMed

30.

Largo R, Alvarez-Soria MA, Diez-Ortega I, Calvo E, Sanchez-Pernaute O, Egido J, Herrero-Beaumont G (2003) Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthr Cartil 11:290–298PubMedCrossRef

31.

Chan PS, Caron JP, Rosa GJ, Orth MW (2005) Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthr Cartil 13:387–394PubMedCrossRef

Titel: Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study
verfasst von: Anna Scotto d’Abusco
Alessandro Corsi
Maria Grazia Grillo
Claudia Cicione
Valentina Calamia
Gianluca Panzini
Anna Sansone
Cesare Giordano
Laura Politi
Roberto Scandurra
Publikationsdatum: 01.03.2008
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 5/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-007-0463-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2008

Pauci-immune glomerulonephritis associated with primary antiphospholipid syndrome

Effect of a modified S-form hip brace, WISH type, for patients with painful osteoarthritis of the hip: a role in daily walking as a hip muscle exercise

The relation of hand functions with radiological damage and disease activity in rheumatoid arthritis

High-frequency sensorineural hearing loss in patients with ankylosing spondylitis: is it an extrarticuler feature of disease?

Successful treatment using tacrolimus plus corticosteroid in a patient with RA associated with MDS

Ochronosis with cardiovascular involvement: a case report

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin